Clinical Trials | July 10, 2025
82% of people prefer diagnostic centers over hospitals for preventive checkups in India
Insights are drawn from over 30K+ people across 300+ cities including all metro and tier-1 cities
Insights are drawn from over 30K+ people across 300+ cities including all metro and tier-1 cities
Annual EBITDA margin expands by 170 basis points
Over the last 24 years, the company's sales has grown from Rs. 478 crores to Rs. 19,022 crores
The company has received final approval from the Department of Pharmaceuticals, Government of India, for foreign investment under applicable regulations
The transaction is expected to be completed by May 15, 2025 or such other date as may be mutually agreed
The system is powered by advanced imaging innovations such as Amber-red Color Imaging, Triple Noise Reduction, and Extended Dynamic Range Image Processing
Over 1500 stakeholders representing food businesses, packaging industries, recycling associations, regulatory bodies, environmental organizations, consumer groups, farmer groups, government departments participated in the consultation
403 entries from 22 states covering 168 districts highlight groundbreaking initiatives vital to improving national nutrition metrics.
Prior to joining Eris, Ranganathan was Commercial Director, Women's Health, Metabolics, and International Business at Abbott India Limited
Cipla Limited has received final approval from the USFDA for the New Drug Application submitted for ‘Nilotinib Capsules 50, 150 and 200 mg’
Subscribe To Our Newsletter & Stay Updated
